Insulet Reports Fourth Quarter And Full Year 2016 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmnipodĀ® Insulin Management System (Omnipod System), today announced financial results for the three months and full year ended December 31, 2016.
Fourth Quarter Highlights and Recent Developments:
Fourth quarter revenue of $103.6 million exceeds the Company's guidance of $99 to $102 million and represents year-over-year growth of 24%.
Fourth Quarter Highlights and Recent Developments:
Fourth quarter revenue of $103.6 million exceeds the Company's guidance of $99 to $102 million and represents year-over-year growth of 24%.